Cefdinir
- Product NDC
- 16714-393
- 11-digit product format
- 167140393
- Labeler code
- 16714
- Product ID
- 16714-393_88c96697-7f83-4497-81aa-a93c95a7a444
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- NorthStar Rx LLC
- Application
- ANDA065473
- Marketing category
- ANDA
- Marketing start
- 2007-12-14
- Marketing end
- 0000-00-00
- Substance
- CEFDINIR
- Active strength
- 250 mg/5mL
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 16714-393 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 16714-393 | 16714-393-01 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 16714-393 | 16714-393-02 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 16714-393-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 16714-393-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 16714-393-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 16714-393-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 16714-393-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 16714-393-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 16714-393-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 16714-393-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 16714-393-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 16714-393-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 16714-393-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 16714-393-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 16714-393-01 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 16714-393-02 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 16714-393-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 16714-393-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 16714-393-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 16714-393-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 16714-393-01 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 16714-393-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 16714-393-01 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 16714-393-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 16714-393-01 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 16714-393-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065473-001 | CEFDINIR | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | |
| A065473-002 | CEFDINIR | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065473-001 | AB |
| A065473-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | RS | 2007-12-14 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065473-001 | CEFDINIR | 125MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A065473-002 | CEFDINIR | 250MG/5ML | FOR SUSPENSION / ORAL | AB | 2007-12-14 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065473-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065473-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065473-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065473-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065473-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065473-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065473-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065473-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065473-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065473-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065473-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065473-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065473-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065473-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065473-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065473-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065473-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065473-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065473-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065473-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065473-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065473-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065473-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065473-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065473-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065473-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065473-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065473-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065473-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065473-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065473-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065473-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065473-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065473-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065473-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065473-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065473-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065473-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065473-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A065473-002 | AB | 1 | 782e0a99824c… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d3e72f63-2c41-955f-f4ce-e90c6403e67c | Product name | 2 | 20210729 |
| e8e66e64-d220-99cb-44eb-0f32dc8cbda1 | Product name | 2 | 20210729 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16714-393-01 | ML - Milliliter | 16714-393 | 4b942663-99a4-4c8f-b3df-325614c49a3a | 1 | 2013-04-01 |
| 16714-393-02 | ML - Milliliter | 16714-393 | 21ecb016-6845-47fb-a970-05dbd4fc482f | 1 | 2013-04-01 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | 5b6c1b5d-a1d5-4e08-9077-2af3f38fea4e | 2026-03-24 | Warnings, Adverse reactions | 065473 ANDA065473 |
| CEFDINIR | CEFDINIR | DIRECT RX | 982d0f53-20bc-1cb4-e053-2995a90ad33c | 2025-01-22 | Warnings | 065473 ANDA065473 |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | 96cad498-70d3-3089-e053-2995a90a9d19 | 2024-06-19 | Warnings, Adverse reactions | 065473 ANDA065473 |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | 8dfbad95-4dd8-01fd-e053-2a95a90a1de1 | 2024-06-18 | Warnings, Adverse reactions | 065473 ANDA065473 |
| Cefdinir | CEFDINIR | A-S Medication Solutions | beeb9480-f9f9-44ae-93f3-6f4da81888f5 | 2024-02-27 | Warnings, Adverse reactions | 065473 ANDA065473 |
| Cefdinir | CEFDINIR | Aurobindo Pharma Limited | 06fbdb63-d32f-4212-9962-f1de15597dda | 2024-02-14 | Warnings, Adverse reactions | 065473 ANDA065473 |
| Cefdinir | CEFDINIR | A-S Medication Solutions | fb02aaab-d2a0-466e-8327-72e3df1e4e9d | 2023-04-04 | Warnings, Adverse reactions | 065473 ANDA065473 |
| Cefdinir | CEFDINIR | Proficient Rx LP | be963e80-e298-49a0-a52f-3d4dcded7c8c | 2022-10-01 | Warnings, Adverse reactions | 065473 ANDA065473 |
| Cefdinir | CEFDINIR | Proficient Rx LP | 8305b5d8-53b3-475a-b263-07d5fd81392a | 2022-09-01 | Warnings, Adverse reactions | 065473 ANDA065473 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 476576 | cefdinir 250 MG in 5 mL Oral Suspension | PSN | ca202c67-f39e-4931-b9f9-bf77259b1bbd | 8 |
| 476576 | cefdinir 50 MG/ML Oral Suspension | SCD | ca202c67-f39e-4931-b9f9-bf77259b1bbd | 8 |
| 476576 | cefdinir 250 MG per 5 ML Oral Suspension | SY | ca202c67-f39e-4931-b9f9-bf77259b1bbd | 8 |
| 476576 | cefdinir 250 MG in 5 mL Oral Suspension | PSN | 8b86e279-8948-44b1-9c51-37afc11b827d | 1 |
| 476576 | cefdinir 250 MG in 5 mL Oral Suspension | PSN | d57d9cf4-1a06-3cfa-e053-2a95a90aae6f | 1 |
| 476576 | cefdinir 50 MG/ML Oral Suspension | SCD | 8b86e279-8948-44b1-9c51-37afc11b827d | 1 |
| 476576 | cefdinir 50 MG/ML Oral Suspension | SCD | d57d9cf4-1a06-3cfa-e053-2a95a90aae6f | 1 |
| 476576 | cefdinir 250 MG per 5 ML Oral Suspension | SY | 8b86e279-8948-44b1-9c51-37afc11b827d | 1 |
| 476576 | cefdinir 250 MG per 5 ML Oral Suspension | SY | d57d9cf4-1a06-3cfa-e053-2a95a90aae6f | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 16714-393-01 | 16714039301 | 1 BOTTLE in 1 CARTON (16714-393-01) > 60 mL in 1 BOTTLE | 1 bottle | 2007-12-14 | 0000-00-00 | No | No | Current |
| 16714-393-02 | 16714039302 | 1 BOTTLE in 1 CARTON (16714-393-02) > 100 mL in 1 BOTTLE | 1 bottle | 2007-12-14 | 0000-00-00 | No | No | Current |